4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-390509
Chief Financial Officer sold 10,810 shares at an average $32.36 ($349,821)
From the SEC's structured data for this filing
Trades in this filing
FRATES JAMES M · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-10 | Sale : show line 1 in the form | −9,768 | $32.27 | $315,195 | 234,667 | D |
| 2026-09-10 | Sale : show line 2 in the form | −1,042 | $33.23 | $34,626 | 233,625 | D |
| Open-market sales · 10,810 sh · avg $32.36 · $349,821 | ||||||
Loading xslF345X06/ownership.xml…